FUM Futura Medical plc

0.0029USD0.2170 GBp · LSE-9.58%Mkt Cap: 4.24M USDP/E: —

Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical treatment for erectile dysfunction. It also develo…

Institutional holders1 on file

Key Statistics

Company
Market Cap4.24M USD
Enterprise Value198.88K USD
Revenue (TTM)3.05M USD
Gross Profit1.63M USD
Net Income (TTM)-11.94M USD
Revenue/Share0.0066 USD
Last Price0.0029 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees13
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINGB0033278473
Valuation
P/E (Trailing)—
P/E (Forward)-0.29
PEG—
EV/EBITDA-0.05
EV/Revenue0.07
P/S1.39
P/B0.72
EPS (TTM)-0.01 USD
EPS (Forward)-0.0098 USD
52W Range
0.00213% of range0.0309
52W High0.0309 USD
52W Low0.0021 USD
Profitability
Gross Margin73.08%
Oper. Margin-133.41%
EBITDA Margin-128.41%
Profit Margin-534.62%
ROE-323.35%
ROA-173.80%
ROIC—
ROCE-165.76%
Growth
Revenue Growth62.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.39M USD
CapEx (TTM)—
FCF Margin-127.80%
FCF Yield-92.06%
Net Debt-1.64M USD
Net Debt/EBITDA0.42
Net Debt/FCF—
Balance Sheet
Debt/Equity—
Current Ratio1.82
Quick Ratio1.82
Book Value/Sh0.0040 USD
Cash/Share0.0026 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.48B
Float371.22M
Insiders43.08%
Institutions10.23%
Technical
SMA 500.0028 (+3.2%)
SMA 2000.0084 (-65.9%)
Beta0.14
S&P 52W Chg12.08%
Avg Vol (30d)15.54M
Avg Vol (10d)25.46M
Technical Indicators
RSI (14)49.3
MACD0.0065
MACD Signal0.0034
MACD Hist.+0.0031
BB Upper0.0036 USD
BB Middle0.0028 USD
BB Lower0.0019 USD
BB Width61.71%
ATR (14)0.0007 USD
Vol Ratio (20d)0.19x

About Futura Medical (LON: FUM)

›

Futura Medical (LON: FUM) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 13 employees.

The shares were at 0.2170 GBp on 19 November 2026, down 90.4% over 52 weeks. Its 52-week range is 0.1595 GBp to 2.350 GBp: the price is 90.8% below the high and 36.1% above the low.

Its market capitalisation is 3.22M GBP.

Futura Medical reports return on equity of -323.4%, an operating margin of -133.4% and revenue up 62.0% year over year.

It holds more cash than debt, a net cash position of 1.24M GBP. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.